Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Cash & Equivalents: 2024

Historic Cash & Equivalents for Pyxis Oncology (PYXS) over the last 1 years, with Dec 2024 value amounting to $19.5 million.

  • Pyxis Oncology's Cash & Equivalents fell 26.02% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year decrease of 26.02%. This contributed to the annual value of $19.5 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Pyxis Oncology's Cash & Equivalents is $19.5 million.
  • In the past 5 years, Pyxis Oncology's Cash & Equivalents ranged from a high of $19.5 million in FY2024 and a low of $19.5 million during FY2024.
  • In the last 1 years, Pyxis Oncology's Cash & Equivalents had a median value of $19.5 million in 2024 and averaged $19.5 million.